
Sign up to save your podcasts
Or
Heather Hayes, Stroke SIG chair, interviews professor Julie Bernhardt. Professor Berhnardt is a clinician researcher at University of Melbourne. She is a National Health and Medical Research Council established fellow and senior principal florey research fellow at the florey Institute of Neuroscience and Mental Health, Melbourne, Australia. Julie has been working with people with stroke for 30 years. She is Head of the Stroke Division at the Florey and leader of the AVERT Early Intervention Research Program. Working in a large multidisciplinary team of researchers, the focus of Julie’s group is the development and testing of new, exercise and rehabilitation interventions that aim to reduce the burden of stroke related disability. Julie is Australia’ leading stroke rehabilitation trialist, recently completing the largest, international trial of early mobility based rehabilitation ever conducted (AVERT) which included over 2000 patients from 5 countries. Listen as Julie discusses findings from her research, applications for clinicians, and here future research direction.
5
55 ratings
Heather Hayes, Stroke SIG chair, interviews professor Julie Bernhardt. Professor Berhnardt is a clinician researcher at University of Melbourne. She is a National Health and Medical Research Council established fellow and senior principal florey research fellow at the florey Institute of Neuroscience and Mental Health, Melbourne, Australia. Julie has been working with people with stroke for 30 years. She is Head of the Stroke Division at the Florey and leader of the AVERT Early Intervention Research Program. Working in a large multidisciplinary team of researchers, the focus of Julie’s group is the development and testing of new, exercise and rehabilitation interventions that aim to reduce the burden of stroke related disability. Julie is Australia’ leading stroke rehabilitation trialist, recently completing the largest, international trial of early mobility based rehabilitation ever conducted (AVERT) which included over 2000 patients from 5 countries. Listen as Julie discusses findings from her research, applications for clinicians, and here future research direction.
14,253 Listeners
365 Listeners
1,155 Listeners
365,438 Listeners
68,854 Listeners
618 Listeners
97,356 Listeners
7,925 Listeners
84 Listeners
34 Listeners
57,901 Listeners
78 Listeners
28,268 Listeners
20,527 Listeners
19 Listeners